NCT01739413

Brief Summary

Epidural anesthesia has been found to manipulate the hyperglycemic response to surgery. It is unclear, however, whether the preoperative metabolic status of the surgical patient plays a role in the degree of this hyperglycemic response. For instance, the presence of low insulin sensitivity before surgery could predispose the individual to an altered metabolic response after surgery. In this case, it would be appropriate to identify adequate interventions that attenuate the response to surgical stress and facilitate the recovery process. The aims of this research projects are the following:

  1. 1.To determine the extent in which epidural local anesthetics, initiated before surgery and continued after surgery, improves insulin secretion in patients with preoperative low insulin sensitivity.
  2. 2.To understand which measures of postoperative recovery are sensitive to the restoration of insulin secretion in this particular group of patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

November 29, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 3, 2012

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

October 10, 2017

Status Verified

October 1, 2017

Enrollment Period

2.9 years

First QC Date

November 29, 2012

Last Update Submit

October 6, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hyperinsulinemic-euglycemic clamp

    The Hyperinsulinemic-euglycemic clamp is the gold standard for measuring insulin sensitivity. Patients receive a 2 hour infusion of glucose and insulin, which is adjusted throughout the study period in order to maintain a blood glucose concentration at 5.5mmol/L. The test will take place one week before surgery and on the second postoperative day.

    up to 2 days after surgery

Study Arms (2)

General Anesthesia

ACTIVE COMPARATOR

Patients will receive general anesthesia alone followed by intravenous morphine for postoperative pain control. This techniques is safe and is standard procedure for colorectal surgery.

Procedure: Anesthesia

Epidural Anesthesia

EXPERIMENTAL

Patients will receive general anesthesia plus epidural anesthesia followed by epidural analgesia for postoperative pain control. This techniques is safe and standard procedure for colorectal surgery.

Procedure: Anesthesia

Interventions

AnesthesiaPROCEDURE

Patients will be randomized to receive either epidural or general anesthesia for pain management throughout their surgery.

Epidural AnesthesiaGeneral Anesthesia

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients receiving elective resection of malignant, non metastatic, colorectal lesions

You may not qualify if:

  • American Society of Anesthesiologists (ASA) health status class 4-5
  • Dementia,neuromuscular disease, psychosis
  • Cardiac abnormalities
  • Severe end-organ disease such as cardiac failure (New York Heart Association classes I-IV)
  • Chronic obstructive pulmonary disease
  • Renal failure (creatinine \> 1.5 mg/dl)
  • Hepatic failure (liver transaminases \>50% over the normal range)
  • Diabetics with glycosylated hemoglobin \> 6%
  • Steroid consumption longer than 30 days sepsis
  • Morbid obesity (body mass index \>40)
  • Anemia (hematocrit \< 30 %, haemoglobin \<10g/dl, albumin \< 25mg/dl).
  • Patients will be excluded if they have poor English or French comprehension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montreal General Hospital

Montreal, Quebec, H3G 1A4, Canada

Location

Related Publications (1)

  • Donatelli F, Corbella D, Di Nicola M, Carli F, Lorini L, Fumagalli R, Biolo G. Preoperative insulin resistance and the impact of feeding on postoperative protein balance: a stable isotope study. J Clin Endocrinol Metab. 2011 Nov;96(11):E1789-97. doi: 10.1210/jc.2011-0549. Epub 2011 Aug 31.

    PMID: 21880795BACKGROUND

MeSH Terms

Interventions

Anesthesia

Intervention Hierarchy (Ancestors)

Anesthesia and Analgesia

Study Officials

  • Francesco Donatelli, MD

    McGill University Health Centre/Research Institute of the McGill University Health Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assitant Professor

Study Record Dates

First Submitted

November 29, 2012

First Posted

December 3, 2012

Study Start

November 1, 2012

Primary Completion

October 1, 2015

Study Completion

November 1, 2015

Last Updated

October 10, 2017

Record last verified: 2017-10

Locations